4//SEC Filing
El-Hibri Fuad 4
Accession 0000899243-21-008483
CIK 0001367644other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 7:22 PM ET
Size
7.9 KB
Accession
0000899243-21-008483
Insider Transaction Report
Form 4
El-Hibri Fuad
DirectorCEO & Chairman10% Owner
Transactions
- Award
Restricted Stock Unit
2021-02-24+13,906→ 13,906 total→ Common Stock (13,906 underlying) - Award
Employee Stock Options (Right to Buy)
2021-02-24+27,808→ 27,808 totalExercise: $93.49Exp: 2031-02-23→ Common Stock (27,808 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On February 24, 2021, Mr. El-Hibri was granted 27,808 stock options vesting in three approximately equal annual installments beginning on the day prior to the first anniversary of the grant date.
- [F3]On February 24, 2021, Mr. El-Hibri was granted 13,906 restricted stock units vesting in three approximately equal annual installments beginning on the day prior to the first anniversary of the grant date.
Documents
Issuer
Emergent BioSolutions Inc.
CIK 0001367644
Entity typeother
Related Parties
1- filerCIK 0001380185
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 7:22 PM ET
- Size
- 7.9 KB